title: Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron.
authors.forename: C
authors.initials: C
authors.lastname: Hutchinson
authors.forename: W
authors.initials: W
authors.lastname: Al-Ashgar
authors.forename: D Y
authors.initials: DY
authors.lastname: Liu
authors.forename: R C
authors.initials: RC
authors.lastname: Hider
authors.forename: J J
authors.initials: JJ
authors.lastname: Powell
authors.forename: C A
authors.initials: CA
authors.lastname: Geissler
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000740:Anemia / Q000097:blood*; D005260:Female; D005296:Ferrous Compounds / Q000008:administration & dosage*; D006801:Humans; D007501:Iron / Q000097:blood*; D017382:Reactive Oxygen Species / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism
chemical_list: D005296:Ferrous Compounds; D017382:Reactive Oxygen Species; D014168:Transferrin; C020748:ferrous sulfate; D007501:Iron